BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/30/2023 12:54:07 PM | Browse: 193 | Download: 634
 |
Received |
|
2023-01-21 04:54 |
|
Peer-Review Started |
|
2023-01-21 04:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-10 09:29 |
|
Revised |
|
2023-03-24 13:36 |
|
Second Decision |
|
2023-06-13 02:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-06-13 08:27 |
|
Articles in Press |
|
2023-06-13 08:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-06-07 11:57 |
|
Typeset the Manuscript |
|
2023-06-15 03:19 |
|
Publish the Manuscript Online |
|
2023-06-30 12:54 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Clinical Neurology |
| Manuscript Type |
Case Report |
| Article Title |
Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Liu Yang, Xin Xu, Liang Wang, Ke-Bin Zeng and Xue-Feng Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xue-Feng Wang, PhD, Professor, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Jiankang Road, Yuzhong District, Chongqing 400010, China. wangxfyp@vip.163.com |
| Key Words |
Edaravone; Sudden death; Patients; Cerebral infarction; Case report |
| Core Tip |
We report three patients with acute cerebral infarction who died after edaravone treatment. Edaravone is used to scavenge oxygen free radicals in patients with acute ischemic stroke, and most clinicians are only aware of its damage to kidney function. However, the main symptoms in patients treated with intravenous edaravone, such as rapid disease change, coagulation dysfunction, cardiac arrest and other side effects are rarely reported. The purpose of this paper is to share the experience of edaravone therapy in clinical practice. |
| Publish Date |
2023-06-30 12:54 |
| Citation |
Yang L, Xu X, Wang L, Zeng KB, Wang XF. Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports. World J Clin Cases 2023; 11(19): 4648-4654 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i19/4648.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i19.4648 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
